ARTICLE | Top Story
Cor's Integrilin compelling with stents
February 4, 2000 8:00 AM UTC
An independent data safety monitoring committee recommended early termination of CORR and partner Schering-Plough's trial of Integrilin in 2,400 patients undergoing stent surgery. After 30 days, the I...